Lista de obras -

Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism

artículo científico publicado en 2009

Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells

artículo científico publicado en 2009

Biocompatible Lipid Nanoparticles as Carriers To Improve Curcumin Efficacy in Ovarian Cancer Treatment.

artículo científico publicado en 2017

COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells.

artículo científico publicado en 2011

Cationic Solid Lipid Nanoparticles as Non Viral Vectors for the Inhibition of Hepatocellular Carcinoma Growth by RNA Interference

artículo científico publicado en 2018

Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells

artículo científico publicado en 2018

Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells

artículo científico publicado en 2014

Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells.

artículo científico publicado en 2004

GSK-3 in liver diseases: Friend or foe?

artículo científico publicado en 2020

Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells

artículo científico publicado en 2007

Identification of an LPS-Induced Chemo-Attractive Peptide from Ciona robusta

scientific article published on 12 April 2020

Involvement of p38 and JNK MAPKs pathways in Substance P-induced production of TNF-alpha by peritoneal mast cells

artículo científico publicado en 2002

Molecular mechanisms of sorafenib action in liver cancer cells.

artículo científico publicado en 2012

Nanoassemblies Based on Supramolecular Complexes of Nonionic Amphiphilic Cyclodextrin and Sorafenib as Effective Weapons to Kill Human HCC Cells

artículo científico publicado en 2015

Nanoparticles of a polyaspartamide-based brush copolymer for modified release of sorafenib: In vitro and in vivo evaluation

artículo científico publicado en 2017

Nanostructured lipid carriers-containing anticancer compounds: preparation, characterization, and cytotoxicity studies

artículo científico publicado en 2007

Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery

artículo científico publicado en 2007

Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells

artículo científico publicado en 2010

Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells.

artículo científico publicado en 2013

Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation

artículo científico publicado en 2017

Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma

artículo científico publicado en 2017

Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.

artículo científico publicado en 2007

Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells

artículo científico publicado en 2018

Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth.

artículo científico publicado en 2009

RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma

scientific article published on 04 November 2019

Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells

artículo científico publicado en 2003

Synthesis and characterization of polyaminoacidic polycations for gene delivery

artículo científico publicado en 2005

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

artículo científico publicado en 2012

Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma

scientific article published on 24 December 2018

The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment

artículo científico publicado en 2020

The novel NF-κB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism.

artículo científico publicado en 2012

The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells

artículo científico publicado en 2006

Lista de obras de

Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism

Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells

Biocompatible Lipid Nanoparticles as Carriers To Improve Curcumin Efficacy in Ovarian Cancer Treatment.

COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells.

Cationic Solid Lipid Nanoparticles as Non Viral Vectors for the Inhibition of Hepatocellular Carcinoma Growth by RNA Interference

Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells

Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells

Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells.

GSK-3 in liver diseases: Friend or foe?

Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells

Identification of an LPS-Induced Chemo-Attractive Peptide from Ciona robusta

Involvement of p38 and JNK MAPKs pathways in Substance P-induced production of TNF-alpha by peritoneal mast cells

Molecular mechanisms of sorafenib action in liver cancer cells.

Nanoassemblies Based on Supramolecular Complexes of Nonionic Amphiphilic Cyclodextrin and Sorafenib as Effective Weapons to Kill Human HCC Cells

Nanoparticles of a polyaspartamide-based brush copolymer for modified release of sorafenib: In vitro and in vivo evaluation

Nanostructured lipid carriers-containing anticancer compounds: preparation, characterization, and cytotoxicity studies

Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery

Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells

Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells.

Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation

Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma

Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway.

Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells

Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth.

RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma

Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells

Synthesis and characterization of polyaminoacidic polycations for gene delivery

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma

The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment

The novel NF-κB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism.

The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells